Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
4.670
-0.050 (-1.06%)
Mar 12, 2026, 11:50 AM EDT - Market open

Strata Critical Medical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
30.9716.0727.8741.342.6
Short-Term Investments
30.26108.76138.26150.74279.37
Cash & Short-Term Investments
61.23124.83166.14192.08281.97
Cash Growth
-50.95%-24.86%-13.51%-31.88%-7.29%
Accounts Receivable
39.9619.8221.0110.885.55
Other Current Assets
2516.0919.1215.177.43
Total Current Assets
126.19160.74206.26218.13294.95
Net Property, Plant & Equipment
39.5531.326.3819.732.76
Other Intangible Assets
47.57.9620.5246.3724.42
Goodwill
88.2115.5440.3739.4513.33
Long-Term Investments
----0.2
Other Long-Term Assets
24.0241.131.41.360.23
Total Assets
325.47256.68294.94325.03335.88
Accounts Payable
19.149.2223.8616.546.37
Current Portion of Leases
0.650.684.793.360.44
Unearned Revenue
--6.856.715.98
Other Current Liabilities
-12.82---
Total Current Liabilities
19.7922.7335.4926.6112.78
Long-Term Leases
2.662.3419.7414.970.28
Other Long-Term Liabilities
23.959.685.418.9631.45
Total Long-Term Liabilities
26.6112.0125.1523.9331.73
Total Liabilities
46.434.7460.6450.5444.51
Common Stock
0.010.010.010.010.01
Additional Paid-in Capital
424.62407.08390.08375.87368.68
Accumulated Other Comprehensive Income
-1.753.962.29-0.9
Retained Earnings
-145.55-186.9-159.75-103.68-76.42
Shareholders' Equity
279.07221.94234.3274.49291.37
Total Liabilities & Equity
325.47256.68294.94325.03335.88
Total Debt
3.313.0224.5318.330.72
Net Cash (Debt)
57.92121.81141.61173.75281.25
Net Cash Growth
-52.45%-13.98%-18.50%-38.22%-7.32%
Net Cash Per Share
0.711.571.932.44-
Book Value
279.07221.94234.3274.49291.37
Book Value Per Share
3.402.863.193.85-
Tangible Book Value
143.36198.43173.41188.68253.62
Tangible Book Value Per Share
1.752.562.362.65-
Updated Mar 3, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q